Resources Contact Us Home
Formulation of quinazoline based EGFR inhibitors containing a zinc binding moiety

Image Number 13 for United States Patent #8119616.

The present invention relates to a composition comprising an inclusion complex of a cyclodextrin and quinazoline containing zinc-binding moiety based derivatives. The cyclodextrin is preferable a .beta.-cyclodextrin or a derivative thereof. The quinazolines have enhanced and unexpected properties as inhibitors of epidermal growth factor receptor tyrosine kinase (EGFR-TK) and their use in the treatment of EGFR-TK related diseases and disorders such as cancer. The said derivatives may further act as HDAC inhibitors.

  Recently Added Patents
Low drop-out regulator providing constant current and maximum voltage limit
Method of transmitting and receiving wireless resource information
Random sampling for geophysical acquisitions
Attribute category enhanced search
Automated incorporation of expert feedback into a monitoring system
Fuel cell support structure
  Randomly Featured Patents
Apparatus for use in producing droplets
Interface for engaging a snowboard boot to a binding
Method of reclaiming styrene and other products from polystyrene based products
Method for passing a fluid through a moving bed of particles
Localized routing direction
Analysis of third party networks
Method for improving water retention qualities of soil and an agent for performing this method
Circuit board/printed circuit board having pre-reserved conductive heating circuits
System, method and computer-accessible medium for making worker distribution plan on the basis of updated skill assessment data
Conditional access method and devices